<qa>  How many subjects will be enrolled in Study Group B?- Approximately 64 to 96 subjects using glucagon-like peptide-1 GLP-1 receptor agonists or sodium-glucose cotransporter 2 SGLT2 inhibitors will be enrolled in Study Group B. 